Sinoway Industrial Co., Ltd.

Celecoxib 169590-42-5 Celecoxib 169590-42-5

Celecoxib 169590-42-5
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.

  • Ceftiofur Sodium 104010-37-9
    Basic information of Ceftiofur sodium:NameCeftiofur sodiumCAS :104010-37-9Molecular FormulaC19H16N5NaO7S3Molecular Weight545.54Quality StandardPackage SizeFor small quantity:Double plastic bag inside ... Ceftiofur Sodium 104010-37-9
  • Emtricitabine 143491-57-0
    Basic information of EmtricitabineNameEmtricitabineAliasEntricitabine;FTC;4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one;EMTRITABINE;EMTRICITABIN;SM-Q;CAS NO.143... Emtricitabine 143491-57-0
  • Orlistat 96829-58-2
    Basic information of OrlistatNameOrlistatCAS96829-58-2EINECSMolecular FormulaC29H53NO5Molecular Weight495.73Quality Standard USP37/ in-house standarad, 98.5%Package Size5kg/tinBrief IntroductionWhite ... Orlistat 96829-58-2
  • Esomeprazole Magnesium 217087-09-7
    Basic information:Other name: Esomeprazole magnesium trihydrate Bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzylimidazole-1-yl) magnesium trihydrateCas no.: 217087-... Esomeprazole Magnesium 217087-09-7

MORE_DETAIL Celecoxib 169590-42-5

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//